CORC  > 昆明医科大学
Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C
Li, Yu-Hua; Xu, Zhi-Yuan; Wu, Hua-Mei; Xu, Ying; Wan, Yue-Meng; Wu, Xi-Nan; Yang, Jin-Hui
刊名JOURNAL OF CLINICAL GASTROENTEROLOGY
2019
卷号53期号:4
关键词acute-on-chronic liver failure (ACLF) chronic hepatitis B (CHB) tenofovir disoproxil fumarate (TDF) entecavir (ETV)
ISSN号0192-0790
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3413552
专题昆明医科大学
推荐引用方式
GB/T 7714
Li, Yu-Hua,Xu, Zhi-Yuan,Wu, Hua-Mei,et al. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C[J]. JOURNAL OF CLINICAL GASTROENTEROLOGY,2019,53(4).
APA Li, Yu-Hua.,Xu, Zhi-Yuan.,Wu, Hua-Mei.,Xu, Ying.,Wan, Yue-Meng.,...&Yang, Jin-Hui.(2019).Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.JOURNAL OF CLINICAL GASTROENTEROLOGY,53(4).
MLA Li, Yu-Hua,et al."Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C".JOURNAL OF CLINICAL GASTROENTEROLOGY 53.4(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace